GlyRS-IN-1 is a glycyl-tRNA synthase (GlyRS) inhibitor disclosed in patent WO 2017066459 A1, and functions by disrupting aminoacyl-tRNA biosynthesis, thereby impairing protein synthesis, GlyRS-IN-1 also suppresses bacterial growth, making it a valuable chemical probe for studying translational machinery, antimicrobial target validation, and the development of novel antibiotics against resistant bacterial pathogens.
Molecular Weight:
403.37
Purity:
99.86%
CAS Number:
[112921-11-6]
Formula:
C12H17N7O7S
Target:
Chloride channel
T11434
T11434
* VAT and and shipping costs not included. Errors and price changes excepted
